Atlas Trials

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Clinical trial NCT01359579 · TERMINATED

Trial details

NCT number
NCT01359579
Sponsor
Anthera Pharmaceuticals
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2011-06-01
Primary completion
2012-04-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.